Antidepressant withdrawal phenomena
- PMID: 6324897
Antidepressant withdrawal phenomena
Abstract
The authors review the antidepressant withdrawal literature. Withdrawal of tricyclic antidepressants may precipitate the development of discrete syndromes. The most common of these are general somatic or gastrointestinal distress with or without anxiety and agitation, sleep disturbance characterized by excessive and vivid dreaming and initial and middle insomnia, movement disorder, and psychic and behavioral activation extending on a continuum to frank mania. The etiology of these syndromes is discussed. The "cholinergic overdrive hypothesis" explains most antidepressant withdrawal phenomena, including infrequent manifestations. Some antidepressant withdrawal symptomatology may be due to an interaction between cholinergic overdrive and monoaminergic systems. A treatment program useful in ameliorating the distress of patients who develop antidepressant withdrawal symptoms and who cannot continue to take antidepressants is outlined. The theoretical significance of tricyclic withdrawal phenomena and the heuristic value of current hypotheses as to their pathophysiology are discussed.
Similar articles
-
Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis.J Clin Psychopharmacol. 1983 Jun;3(3):157-64. J Clin Psychopharmacol. 1983. PMID: 6348107 Review.
-
[Withdrawal syndrome from antidepressive drugs. Report of 5 cases].Encephale. 1992 May-Jun;18(3):251-5. Encephale. 1992. PMID: 1299596 French.
-
Antidepressant withdrawal-induced activation (hypomania and mania): mechanism and theoretical significance.Brain Res. 1984 Mar;319(1):29-48. doi: 10.1016/0165-0173(84)90028-6. Brain Res. 1984. PMID: 6143595 Review.
-
The jitteriness syndrome in panic disorder patients treated with antidepressants.J Clin Psychiatry. 1988 Mar;49(3):100-4. J Clin Psychiatry. 1988. PMID: 3346196
-
[Withdrawal reactions after clomipramine].Harefuah. 1992 Oct;123(7-8):252-5, 307. Harefuah. 1992. PMID: 1459499 Hebrew.
Cited by
-
Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.CNS Drugs. 2002;16(4):273-83. doi: 10.2165/00023210-200216040-00006. CNS Drugs. 2002. PMID: 11945110 Clinical Trial.
-
Antidepressant Withdrawal and Rebound Phenomena.Dtsch Arztebl Int. 2019 May 17;116(20):355-361. doi: 10.3238/arztebl.2019.0355. Dtsch Arztebl Int. 2019. PMID: 31288917 Free PMC article. Review.
-
Clomipramine concentration and withdrawal symptoms in 10 neonates.Br J Clin Pharmacol. 2012 Feb;73(2):295-302. doi: 10.1111/j.1365-2125.2011.04072.x. Br J Clin Pharmacol. 2012. PMID: 21801198 Free PMC article.
-
Withdrawal phenomena associated with antidepressant and antipsychotic agents.Drug Saf. 1994 Feb;10(2):103-14. doi: 10.2165/00002018-199410020-00002. Drug Saf. 1994. PMID: 7912078 Review.
-
Genetic and pharmacological models of cholinergic supersensitivity and affective disorders.Experientia. 1988 Jun 15;44(6):465-72. doi: 10.1007/BF01958920. Experientia. 1988. PMID: 3288493 Review.